Walleye Capital’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Sell |
|
|||||
|
2025
Q1 | $1.66M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $330K | Buy |
|
|||||
|
2023
Q3 | $5.15K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $607K | Sell |
|
|||||
|
2022
Q4 | $568K | Buy |
|
|||||
|
2022
Q3 | $405K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $399K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $238 | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $601K | Buy |
|
|||||
|
2020
Q2 | $248K | Sell |
|
|||||
|
2020
Q1 | $358K | Buy |
|
|||||
|
2019
Q4 | $7K | Buy |
|
|||||
|
2019
Q3 | $3K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $10K | Buy |
|